Ilepatril, a vasopeptidase inhibitor, was investigated in obese Zucker diabetic fatty (ZDF) rats as a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase for treating Type 2 diabetic nephropathy. Despite stable diabetes (HbA1c >12%)
Molecular Weight:
432.53
CAS Number:
[473289-62-2]
Formula:
C22H28N2O5S
Target:
Angiotensin-converting Enzyme (ACE)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted